Spirit Tech - How to wire your brain for religious ecstasy By John Horgan published in Slate Magazine on April 26, 2007 http://www.slate.com/id/2165004/ Eight years ago, I flew to Laurentian University …
The MAPS-sponsored study in Israel evaluating MDMA-assisted psychotherapy for subjects with war-and terrorism-related posttraumatic stress disorder (PTSD) has full government approval and is now in the …
Alcohol worse than ecstasy on shock new drug list By: James Randerson, science correspondent Published on Friday, 23 March 2007 in The Guardian http://www.guardian.co.uk/drugs/Story/0,,2040886,00.html …
Dr. Peter Oehen’s MAPS-sponsored study evaluating MDMA-assisted psychotherapy for subjects with chronic posttraumatic stress disorder (PTSD) has been making swift progress. Last Thursday, March 8, …
One morning in 2006, MAPS founder and executive director Rick Doblin, Ph.D., learned of a violent crime that had occurred a few houses away from the MAPS office in Ben Lomond, California. “I starting …
Dr. Peter Oehen conducted the second experimental MDMA-assisted psychotherapy session with the second subject in his ongoing MAPS-sponsored MDMA-assisted therapy pilot study for subjects with treatment-resistant …
Principal Investigator Peter Oehen, M.D., officially initiated the Swiss MAPS-sponsored pilot study evaluating MDMA-assisted psychotherapy for subjects with treatment-resistant posttraumatic stress disorder …
Dr. Peter Oehen’s MAPS-sponsored MDMA/PTSD protocol has full government approval and the first subject began the screening process last week. The Ethics Committee (the Swiss IRB equivalent, which …
The Israeli Import Permit and the Swiss Export Permit have now been approved. On Thursday, August 3rd, in the midst of war, about 5 grams of MDMA arrived in Israel for MAPS’ MDMA/PTSD study, imported …
Switzerland’s DEA equivalent, the BAG, has officially approved Dr. Peter Oehen’s MAPS-sponsored study evaluating MDMA-assisted psychotherapy as a treatment for subjects suffering from treatment-resistant …
Switzerland’s FDA equivalent, SwissMedic, has now fully approved Dr. Peter Oehen’s MAPS-sponsored MDMA/PTSD study. The protocol design had already been approved, and earlier this week we received …
